A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports

Multisystem inflammatory syndrome in children is a newly described condition temporarily associated with severe acute respiratory syndrome coronavirus 2. The primary observations indicated coronavirus disease 2019 infection in children to be mild. However, recent reports have revealed a correlation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Agnieszka Poniecka, Elżbieta Smolewska
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2021
Materias:
R
Acceso en línea:https://doaj.org/article/beaf766e0d884c32839a66f37c38738a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:beaf766e0d884c32839a66f37c38738a
record_format dspace
spelling oai:doaj.org-article:beaf766e0d884c32839a66f37c38738a2021-12-02T19:19:13ZA fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports0034-62332084-983410.5114/reum.2021.102871https://doaj.org/article/beaf766e0d884c32839a66f37c38738a2021-02-01T00:00:00Zhttps://www.termedia.pl/A-fine-line-between-macrophage-activation-syndrome-and-multisystem-inflammatory-syndrome-in-children-literature-review-based-on-two-case-reports,18,43087,1,1.htmlhttps://doaj.org/toc/0034-6233https://doaj.org/toc/2084-9834Multisystem inflammatory syndrome in children is a newly described condition temporarily associated with severe acute respiratory syndrome coronavirus 2. The primary observations indicated coronavirus disease 2019 infection in children to be mild. However, recent reports have revealed a correlation between multisystem inflammatory symptoms and coronavirus infection. The manifestation of the disease is similar to Kawasaki disease, toxic shock syndrome and macrophage acti­vation syndrome. Treatment includes intravenous corticosteroids, immunoglobulin and biological therapy (anakinra, tocilizumab, infliximab). In this article we compare world reports of multisystem inflammatory syndrome in children to case reports of two patients who were hospitalized recently at the Department of Paediatric Cardio­logy and Rheumatology. In the course of diagnostics they presented numerous symptoms which required differentiation from multisystem inflammatory syndrome in children.Agnieszka PonieckaElżbieta SmolewskaTermedia Publishing Housearticlepaediatric multisystem inflammatory syndrome sars-cov-2 infection secondary haemophagocytic lymphohistiocytosis macrophage activation syndrome.MedicineRENRheumatology, Vol 59, Iss 1, Pp 47-57 (2021)
institution DOAJ
collection DOAJ
language EN
topic paediatric multisystem inflammatory syndrome
sars-cov-2 infection
secondary haemophagocytic lymphohistiocytosis
macrophage activation syndrome.
Medicine
R
spellingShingle paediatric multisystem inflammatory syndrome
sars-cov-2 infection
secondary haemophagocytic lymphohistiocytosis
macrophage activation syndrome.
Medicine
R
Agnieszka Poniecka
Elżbieta Smolewska
A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
description Multisystem inflammatory syndrome in children is a newly described condition temporarily associated with severe acute respiratory syndrome coronavirus 2. The primary observations indicated coronavirus disease 2019 infection in children to be mild. However, recent reports have revealed a correlation between multisystem inflammatory symptoms and coronavirus infection. The manifestation of the disease is similar to Kawasaki disease, toxic shock syndrome and macrophage acti­vation syndrome. Treatment includes intravenous corticosteroids, immunoglobulin and biological therapy (anakinra, tocilizumab, infliximab). In this article we compare world reports of multisystem inflammatory syndrome in children to case reports of two patients who were hospitalized recently at the Department of Paediatric Cardio­logy and Rheumatology. In the course of diagnostics they presented numerous symptoms which required differentiation from multisystem inflammatory syndrome in children.
format article
author Agnieszka Poniecka
Elżbieta Smolewska
author_facet Agnieszka Poniecka
Elżbieta Smolewska
author_sort Agnieszka Poniecka
title A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
title_short A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
title_full A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
title_fullStr A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
title_full_unstemmed A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
title_sort a fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
publisher Termedia Publishing House
publishDate 2021
url https://doaj.org/article/beaf766e0d884c32839a66f37c38738a
work_keys_str_mv AT agnieszkaponiecka afinelinebetweenmacrophageactivationsyndromeandmultisysteminflammatorysyndromeinchildrenliteraturereviewbasedontwocasereports
AT elzbietasmolewska afinelinebetweenmacrophageactivationsyndromeandmultisysteminflammatorysyndromeinchildrenliteraturereviewbasedontwocasereports
_version_ 1718376875617681408